Wheel Strategy on XLV: Healthcare Sector Wheeling for Defensive Income
What's in this guide
1. What XLV holds 2. Why wheel healthcare sector 3. Premium math 4. Wheel mechanics 5. When healthcare outperforms 6. XLV vs UNH, JNJ, MRK 7. Position sizing 8. Next stepsXLV (Health Care Select SPDR) holds a diversified basket of US healthcare companies — pharma giants, biotech, medical devices, insurance, and services. For wheelers wanting healthcare exposure without picking between JNJ/UNH/MRK, XLV offers a diversified alternative with defensive characteristics and reasonable premium. This guide walks through the mechanics.
1. What XLV holds
- Holdings: ~65 US healthcare companies
- Top holdings: LLY (~10%), UNH (~8%), JNJ (~7%), MRK (~5%), ABBV (~5%), PFE (~4%)
- Sub-sectors: pharma, biotech, medical devices, health insurance, services
- Expense ratio 0.09%
- Dividend yield ~1.5%
- Options liquidity: excellent
2. Why wheel healthcare sector
- Defensive sector positioning — recession-resilient (people still get sick)
- Diversification across pharma/biotech/devices/insurance
- Reasonable premium — healthcare has moderate IV
- Long-term demographic tailwind — aging populations
- Better than picking single pharma names — avoid single-drug/patent risk
- Multiple growth drivers — GLP-1 (LLY), oncology, biotech innovation
3. Premium math
| Metric | XLV (~$140) | UNH (~$580) | JNJ (~$150) |
|---|---|---|---|
| Cash per contract | ~$14,000 | ~$58,000 | ~$15,000 |
| 30-DTE 20Δ put premium | ~$160 | ~$800 | ~$150 |
| % of strike | ~1.1% | ~1.4% | ~1.0% |
| Annualized (approx) | ~14% | ~17% | ~12% |
| Dividend yield | 1.5% | 1.5% | 3.0% |
XLV pays modest premium — reflecting healthcare's defensive lower-volatility nature. Not the highest-yield sector wheel, but consistent.
4. Wheel mechanics
Cash-secured put entry
- Target: 30-45 DTE at 0.20-0.25 delta
- Strike: 3-5% below current
- Cash required: ~$13-15k per contract
- Premium: ~$130-180 per contract
Covered call after assignment
- Target: 30-45 DTE at 0.20-0.25 delta
- Modest 1.5% dividend while holding
- Sector rallies are muted — CCs less likely to be blown out
5. When healthcare outperforms
- Late economic cycle — defensive sectors lead
- Recession fears — flight to safety helps healthcare
- Innovation cycles — GLP-1 boom lifted LLY dramatically
- Fed cutting cycles — growth stocks benefit but healthcare also participates
- Political stability — healthcare hurt by policy uncertainty (elections)
Healthcare tends to underperform during aggressive risk-on periods (2020-2021 growth rally, tech-driven markets) and outperform during defensive rotations (2022 bear market, recession scares).
6. XLV vs UNH, JNJ, MRK
| Option | Premium (ann.) | Cash per contract | Diversification | Best for |
|---|---|---|---|---|
| XLV (sector) | ~14% | ~$14,000 | High | Diversified healthcare exposure |
| UNH (insurance) | ~17% | ~$58,000 | Low | Concentrated insurance bet, large accounts |
| JNJ (defensive) | ~12% | ~$15,000 | Low (single-name) | Ultra-defensive core position |
| MRK (oncology) | ~15% | ~$10,500 | Low | Pharma exposure with Keytruda story |
7. Position sizing
- XLV-specific cap: 5-15% of wheel capital
- Total healthcare exposure: 10-25% including individual pharma/biotech
- Watch for double-exposure — XLV + JNJ + UNH = triple healthcare since JNJ/UNH are top XLV holdings
- Good defensive core — reliable during risk-off periods
8. Next steps
- Consider XLV for diversified healthcare exposure
- Cap at 5-15% of wheel capital
- Understand defensive positioning — outperforms in late cycles/recessions
- Choose XLV vs individual names based on account size
- Read JNJ guide for ultra-defensive alternative
For real weekly wheel trades including healthcare allocation, the Omega Membership shares the trade plan. Or grab the free Starter Kit.
New to Omega Income Club?
Omega is a wheel-first options-income newsroom — free posts, a starter kit, a paid weekly trade plan, and a small members’ Discord. No hype, just the math.
Explore the site → Free Starter KitFrequently asked questions
Should I wheel XLV?
Yes if you want diversified healthcare sector exposure with defensive characteristics and reasonable premium (~14% annualized). XLV holds 65 healthcare companies — pharma, biotech, devices, insurance, services. Good defensive core position, particularly during late economic cycles or recession scares. Cap at 5-15% of wheel capital.
What does XLV actually hold?
~65 US healthcare companies, market-cap weighted. Top holdings: LLY (~10%), UNH (~8%), JNJ (~7%), MRK (~5%), ABBV (~5%), PFE (~4%). Sub-sectors: pharma (largest), biotech, medical devices, health insurance (UNH, ELV, HUM), healthcare services. Diverse business mix within healthcare umbrella.
How much premium does XLV pay?
A 30-DTE 20Δ XLV put pays ~$160 per contract (~1.1% of strike, ~14% annualized). Plus 1.5% dividend on shares if assigned. Modest premium reflecting healthcare's defensive lower-volatility nature. Less premium than XLE (~16%) or XLK (~15%) but more consistent through cycles.
When does healthcare outperform other sectors?
Five main scenarios: (1) late economic cycle when defensive sectors lead, (2) recession fears causing flight to safety, (3) innovation cycles (GLP-1 boom lifted LLY dramatically), (4) Fed cutting cycles help all sectors including healthcare, (5) political stability (healthcare hurt by policy uncertainty during elections). Underperforms during aggressive risk-on tech rallies.
How does XLV compare to UNH or JNJ for wheeling?
XLV: ~65 holdings, ~14% ann. premium, high diversification, $14k per contract. UNH: single-name insurance, ~17% ann. premium, low diversification, $58k per contract (requires large account). JNJ: defensive core, ~12% ann. premium, $15k per contract, ultra-defensive characteristics. XLV wins for diversification; individual names for concentrated bets.
What position size is right for XLV wheeling?
Cap XLV at 5-15% of wheel capital. Total healthcare exposure (XLV + individual pharma/biotech): 10-25%. Watch for double-exposure — XLV + JNJ + UNH = triple healthcare exposure since JNJ/UNH are top XLV holdings. Good defensive core allowing meaningful sizing in defensive-tilted portfolios.
What are the risks of wheeling XLV?
Five main risks: (1) political/policy risk (drug pricing legislation, healthcare reform), (2) FDA regulatory decisions on major drug approvals, (3) patent cliff on top holdings (PFE 2026-2030 patent expirations), (4) insurance regulation affecting UNH-type companies, (5) biotech binary events. Diversification reduces single-name impact but sector risks remain.
Is healthcare recession-resistant?
Yes, more than most sectors. People still need medical care during recessions. Healthcare stocks typically outperform S&P during economic downturns. But not immune — 2020 COVID hurt healthcare as elective procedures postponed. Long-term demographic tailwinds (aging populations) support continued sector growth regardless of cycle.